Clinical Trial Update: Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of transcranial direct current stimulation for the cerebellar variant of Multiple System Atrophy (MSA-C).…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• Transcranial Direct Current Stimulation (transcranial direct current stimulation)

Snippet

Sponsor: University of Salerno | Conditions: Multiple System Atrophy - Cerebellar Subtype (MSA-C) | NA | Status: RECRUITING